Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-8800
Fax+1 214-645-8801
Dr. Shakkottai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Vikram Shakkottai is a neurologist based in Dallas, TX, specializing in movement disorders and neurodegenerative diseases. He completed his neurology residency at Washington University/B-JH/SLCH Consortium from 2004 to 2008 and graduated from Christian Medical College Vellore in 2000. He obtained a Ph.D. in physiology and biophysics at the University of California, Irvine. His expertise includes movement disorders, cerebellar ataxia, and Parkinson's disease. Dr. Shakkottai has contributed to several publications focused on spinocerebellar ataxias and related topics. He has led clinical trials investigating pharmacokinetic studies and biomarkers in spinocerebellar ataxias. He holds the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR, awarded by Epic Systems Corporation.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2004 - 2008
University of California, IrvinePh.D., 2000 - 2004
Christian Medical College VelloreClass of 2000
Certifications & Licensure
TX State Medical License 2020 - 2026
MI State Medical License 2008 - 2025
MO State Medical License 2004 - 2008
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias Start of enrollment: 2010 Apr 01
- Clinical Trial Readiness for SCA1 and SCA3 Start of enrollment: 2018 Aug 16
- Identification of Biomarkers in Spinocerebellar Ataxia 3 Start of enrollment: 2019 Feb 21
- Join now to see all
Publications & Presentations
PubMed
- Spinocerebellar Ataxia Progression Measured with the Patient-Reported Outcome Measure of Ataxia.Anna L Burt, Gilbert L'Italien, Susan L Perlman, Liana S Rosenthal, Sheng-Han Kuo
Movement Disorders. 2025-03-04 - Increased intrinsic membrane excitability is associated with olivary hypertrophy in spinocerebellar ataxia type 1.Logan M Morrison, Haoran Huang, Hillary P Handler, Min Fu, Deborah M Jones
Human Molecular Genetics. 2024-12-06 - 2 citationsClinical, Radiological and Pathological Features of a Large American Cohort of Spinocerebellar Ataxia (SCA27B).Widad Abou Chaar, Anirudh N Eranki, Hannah A Stevens, Sonya L Watson, Darice Y Wong
Annals of Neurology. 2024-12-01
Journal Articles
- Targeted Exome Analysis Identifies the Genetic Basis of Disease in over 50% of Patients with a Wide Range of Ataxia-Related PhenotypesChristopher M Gomez, Vikram Shakkottai, Darrel J Waggoner, Nature
Press Mentions
Grant Worth up to $5 Million Aids Research for Cerebellar DisordersApril 2nd, 2025
Grant Support
- Understanding Degeneration in Neurons of the Inferior Olivary NucleusUT SOUTHWESTERN MEDICAL CENTER2024–2029
- Identifying symptomatic and neuroprotective strategies for cereballar ataxiaUT SOUTHWESTERN MEDICAL CENTER2021–2025
- Targeting Physiologic Changes As A Route Towards Therapy For Degenerative AtaxiasNational Institute Of Neurological Disorders And Stroke2010–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
